ArticleFrontiers in public health2025
Intervention strategies for type 2 diabetes prevention in high-income countries targeting low socioeconomic groups: a scoping review.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Factors Influencing Poor Drug Compliance Among Patients with Diabetes Mellitus: An Experience from Rural Indonesia.Journal of multidisciplinary healthcare · 2026Article
- Clinical efficacy, safety, and predictors of treatment response to SGLT2 versus DPP-4 inhibitors in type 2 diabetes: a retrospective comparative study.Frontiers in endocrinology · 2026Article
- Intervention strategies for type 2 diabetes prevention in high-income countries targeting low socioeconomic groups: a scoping review.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Type 2 diabetes is increasing worldwide, and the trend is also observed in Sweden. In Malmö, the third largest city in Sweden, the prevalence has doubled. Populations with lower socioeconomic status have a higher prevalence and poorer outcomes, making preventive interventions targeting these groups increasingly important. Objective: To investigate the types of interventions that have been tested and reported regarding the prevention of type 2 diabetes targeting low socioeconomic populations and are applicable in a high-income country. Methods: Based on a systematic search strategy developed using the People, Concept, and Context model, the databases CINAHL, PubMed, and Web of Science were searched in January 2024 and updated in December 2024, and EMBASE was searched in May 2025. A flowchart of the screening process has been created. From the selected studies, data were extracted, charted, and the findings were compiled in a narrative form. Results: Seventeen studies were included, 12 were conducted in the United States and five in Europe. Most used culturally adapted diabetes prevention programs, and a higher proportion of participants were women. Key features included flexibility in attendance and format, development through a community-based participatory approach, gender-specific groups, and the involvement of significant others. Increases of physical activity proved challenging within broader lifestyle interventions. Screening interventions were conducted in community and healthcare facility settings, as well as through a school-and community-based program. Challenges with enrollment and retention were commonly reported. Conclusion: There is a need for more interventions in the European context and for interventions to engage more men with strategies such as male peer coaches and community screening in locations frequented by men. Longer time frames and sustained engagement strategies are necessary to reach and retain groups with low socioeconomic status in preventive type 2 diabetes interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.